EC Healthcare (HKG:2138) recorded a profit attributable to equity shareholders of HK$14.1 million for the six months ended Sept. 30, higher than HK$6.7 million logged for the corresponding period last year, a Thursday filing with the Hong Kong Exchange said.
Earnings per share attributable to equity shareholders stood at HK$0.012 for the reporting period, compared with HK$0.006 recorded for the year-ago period.
The non-hospital medical service provider's revenue for the six months under review was HK$2.06 billion, 2.8% lower than HK$2.12 billion booked a year ago.
The board recommended an interim dividend of HK$0.010 per share for the reporting period, as compared with HK$0.005 per share a year earlier.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。